0001818382-23-000095.txt : 20230616 0001818382-23-000095.hdr.sgml : 20230616 20230616161332 ACCESSION NUMBER: 0001818382-23-000095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230615 FILED AS OF DATE: 20230616 DATE AS OF CHANGE: 20230616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brown Emery N. CENTRAL INDEX KEY: 0001878691 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39532 FILM NUMBER: 231021242 MAIL ADDRESS: STREET 1: 34 FRANCIS STREET CITY: BROOKLINE STATE: MA ZIP: 02446 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Humacyte, Inc. CENTRAL INDEX KEY: 0001818382 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851763759 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-313-9633 MAIL ADDRESS: STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: Alpha Healthcare Acquisition Corp. DATE OF NAME CHANGE: 20200716 4 1 wf-form4_168694639954421.xml FORM 4 X0407 4 2023-06-15 0 0001818382 Humacyte, Inc. HUMA 0001878691 Brown Emery N. 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 1 0 0 0 0 Stock Options (right to buy) 3.35 2023-06-15 4 A 0 8500 0 A 2033-06-15 Common Stock 8500.0 8500 D The first 25% of the option becomes exercisable on June 15, 2024, after which 1/48 of the option will become exercisable on the 15th of each month through June 15, 2027. /s/ Emery N. Brown by Dale A.Sander as Attorney-in-Fact 2023-06-16